Literature DB >> 25980836

Reduced survival in microscopic polyangiitis patients with pulmonary fibrosis in a respiratory referral centre.

Luis Felipe Flores-Suárez1, Natllely Ruiz, Lina María Saldarriaga Rivera, Lya Pensado.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25980836     DOI： 10.1007/s10067-015-2967-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  8 in total

Review 1.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-01-15       Impact factor: 21.405

2.  Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI).

Authors:  A R Exley; P A Bacon; R A Luqmani; G D Kitas; D M Carruthers; R Moots
Journal:  Br J Rheumatol       Date:  1998-01

3.  Incidence of myeloperoxidase anti-neutrophil cytoplasmic antibody positivity and microscopic polyangitis in the course of idiopathic pulmonary fibrosis.

Authors:  Masaru Ando; Eishi Miyazaki; Toshihiro Ishii; Yutaka Mukai; Mari Yamasue; Hideaki Fujisaki; Takeo Ito; Shin-ichi Nureki; Toshihide Kumamoto
Journal:  Respir Med       Date:  2013-02-19       Impact factor: 3.415

Review 4.  Idiopathic pulmonary fibrosis.

Authors:  Talmadge E King; Annie Pardo; Moisés Selman
Journal:  Lancet       Date:  2011-06-28       Impact factor: 79.321

5.  Modification and validation of the Birmingham Vasculitis Activity Score (version 3).

Authors:  C Mukhtyar; R Lee; D Brown; D Carruthers; B Dasgupta; S Dubey; O Flossmann; C Hall; J Hollywood; D Jayne; R Jones; P Lanyon; A Muir; D Scott; L Young; R A Luqmani
Journal:  Ann Rheum Dis       Date:  2008-12-03       Impact factor: 19.103

6.  Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis.

Authors:  G E Tzelepis; M Kokosi; A Tzioufas; S P Toya; K A Boki; A Zormpala; H M Moutsopoulos
Journal:  Eur Respir J       Date:  2009-11-19       Impact factor: 16.671

7.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01

Review 8.  Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature.

Authors:  Cloé Comarmond; Bruno Crestani; Abdellatif Tazi; Baptiste Hervier; Sylvain Adam-Marchand; Hilario Nunes; Fleur Cohen-Aubart; Marie Wislez; Jacques Cadranel; Bruno Housset; Célia Lloret-Linares; Pascal Sève; Christian Pagnoux; Sébastien Abad; Juliette Camuset; Boris Bienvenu; Michaël Duruisseaux; Eric Hachulla; Jean-Benoît Arlet; Mohammed Hamidou; Alfred Mahr; Matthieu Resche-Rigon; Anne-Laure Brun; Philippe Grenier; Patrice Cacoub; David Saadoun
Journal:  Medicine (Baltimore)       Date:  2014-11       Impact factor: 1.889
  8 in total
  4 in total

Review 1.  Pulmonary Involvement in Systemic Vasculitis.

Authors:  Luis Felipe Flores-Suárez; Marco A Alba; Heidegger Mateos-Toledo; Natllely Ruiz
Journal:  Curr Rheumatol Rep       Date:  2017-09       Impact factor: 4.592

Review 2.  Interstital lung disease in ANCA vasculitis.

Authors:  Marco A Alba; Luis Felipe Flores-Suárez; Ashley G Henderson; Hong Xiao; Peiqi Hu; Patrick H Nachman; Ronald J Falk; J Charles Jennette
Journal:  Autoimmun Rev       Date:  2017-05-04       Impact factor: 9.754

3.  Interstitial lung disease and microscopic polyangiitis in chilean patients.

Authors:  Pamela Wurmann; Francisca Sabugo; Fabian Elgueta; Macarena Mac-Namara; Karen Vergara; Daniela Vargas; Maria Luisa Molina; Juan Carlos Díaz; Hector Gatica; Annelise Goecke
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-15       Impact factor: 0.670

Review 4.  MPO-ANCA positive interstitial pneumonia: Current knowledge and future perspectives.

Authors:  Masashi Bando; Sakae Homma; Masayoshi Harigai
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2022-01-13       Impact factor: 1.803
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.